Back
ESC Premium Access

Prevalences and incidences of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: a nationwide observational study

Session: Risk Factors and Prevention ePosters
Topic: Diabetes and the Heart
Speaker: Professor L. Fauchier (Tours, FR)
Event: ESC Congress 2021 - The Digital Experience

Presentation

0

About the speaker

Professor Laurent Fauchier

Tours Regional University Hospital, Hospital Trousseau, Tours (France)
12 presentations
1 follower

224 more presentations in this session

High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events

Speaker: Doctor B. Keskin (Istanbul, TR)

Access
Abstract
Slides
0
Thumbnail

Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines

Speaker: Doctor R. Ong (Makati, PH)

Access
Abstract
Slides
0
Thumbnail

Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project

Speaker: Doctor A. Bendary (Benha, EG)

Access
Abstract
Slides
0
Thumbnail

SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization

Speaker: Mr R. Gascuena (Leganes, ES)

Access
Abstract
Slides
0
Thumbnail

Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome

Speaker: Doctor S. Vohra (Lucknow, IN)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Risk Factors and Prevention ePosters

Speakers: Professor L. Fauchier, Doctor B. Keskin, Doctor R. Ong, Doctor A. Bendary, Mr R. Gascuena...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

Open Access

Live panel discussion.

27 August 2021

ESC Premium Access

Colchicine in Acute Myocardial Infarction

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

This platform is supported by

logo Novo Nordisk